University of Kansas researchers launch COVID-19 study

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at the University of Kansas Medical Center have begun a study exploring an investigational drug, ATI-450, intended to fight the cytokine storm associated with COVID-19.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login